Abstract CT068: A Phase I trial of LXS196, a novel PKC inhibitor for metastatic uveal melanoma
2004 ◽
Vol 40
(14)
◽
pp. 2047-2052
◽
Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients
2005 ◽
Vol 92
(11)
◽
pp. 1997-2003
◽